Pr Thierry SchaeverbekeRhumatologue à Bordeaux

2025Joint bone spinePubMed

Resolution of immune checkpoint inhibitors-induced inflammatory arthritis while maintaining active treatment with checkpoint inhibitors and after its discontinuation: An observational study

2023RMD openPubMed

Immune checkpoint inhibitor rechallenge in patients who previously experienced immune-related inflammatory arthritis: a multicentre observational study

2022RMD openPubMed

Use of a bDMARD or tsDMARD for the management of inflammatory arthritis under checkpoint inhibitors: an observational study

2021Revue du rhumatisme (Ed. francaise : 1993)PubMed

Prise en charge des patients atteints de maladies rhumatismales pendant la pandémie de COVID-19 : la Société française de rhumatologie répond aux questions fréquentes posées jusqu’en mai 2020

2020Joint bone spinePubMed

Managing patients with rheumatic diseases during the COVID-19 pandemic: The French Society of Rheumatology answers to most frequently asked questions up to May 2020

2020Rheumatology (Oxford, England)PubMed

A simplified radiographic score effectively predicts radiographic progression of early arthritis in a large nationwide French cohort

2020Joint bone spinePubMed

Implications of COVID-19 for the management of patients with inflammatory rheumatic diseases

2023Joint bone spinePubMed

Clinical and immunological features of patients with cancer-associated systemic sclerosis: An observational study

2022Arthritis & rheumatology (Hoboken, N.J.)PubMed

Interleukin-1β-Activated Microvascular Endothelial Cells Promote DC-SIGN-Positive Alternatively Activated Macrophages as a Mechanism of Skin Fibrosis in Systemic Sclerosis

2021Annals of the rheumatic diseasesPubMed

TGFβ promotes low IL10-producing ILC2 with profibrotic ability involved in skin fibrosis in systemic sclerosis

2021Seminars in arthritis and rheumatismPubMed

Systemic sclerosis overlap and non-overlap syndromes share clinical characteristics but differ in prognosis and treatments

2021Rheumatology (Oxford, England)PubMed

Rapidly progressive interstitial lung disease under FOLFOX treatment for colorectal cancer associated with systemic sclerosis: two case reports

2020The Journal of investigative dermatologyPubMed

Decreased CCN3 in Systemic Sclerosis Endothelial Cells Contributes to Impaired Angiogenesis

2024Rheumatology (Oxford, England)PubMed

Can efficacy and safety data from clinical trials of rituximab in RA be extrapolated? Insights from 1984 patients from the AIR-PR Registry

2024Arthritis & rheumatology (Hoboken, N.J.)PubMed

Towards the Lowest Efficacious Dose: Results From a Multicenter Noninferiority Randomized Open-Label Controlled Trial Assessing Tocilizumab or Abatacept Injection Spacing in Rheumatoid Arthritis in Remission

2022Joint bone spinePubMed

Improvement in patient-reported outcomes in rheumatoid arthritis patients treated with sarilumab is independent of the cognition levels

2022Rheumatology (Oxford, England)PubMed

Risk of diverticulitis and gastrointestinal perforation in rheumatoid arthritis treated with tocilizumab compared to rituximab or abatacept

2021The Journal of rheumatologyPubMed

Real-world Risk of Relapse of Giant Cell Arteritis Treated With Tocilizumab: A Retrospective Analysis of 43 Patients

2024Rheumatology (Oxford, England)PubMed

Evolution of monoclonal gammopathy of undetermined significance in patients treated with JAK inhibitors for rheumatic diseases: data from the MAJIK-SFR registry

2023Joint bone spinePubMed

Treatment patterns in patients with rheumatoid arthritis initiating a JAK inhibitor or a TNF inhibitor based on retail pharmacies drug-dispensing data

2022European journal of clinical pharmacologyPubMed

JAK inhibitors and risk of major cardiovascular events or venous thromboembolism: a self-controlled case series study

2021Rheumatology (Oxford, England)PubMed

Evaluation of the impact of a nurse-led program of patient self-assessment and self-management in axial spondyloarthritis: results of a prospective, multicentre, randomized, controlled trial (COMEDSPA)

2020BMJ openPubMed

GlutenSpA trial: protocol for a randomised double-blind placebo-controlled trial of the impact of a gluten-free diet on quality of life in patients with axial spondyloarthritis

2020Seminars in arthritis and rheumatismPubMed

Evaluation of the impact of a nurse-led program of systematic screening of comorbidities in patients with axial spondyloarthritis: The results of the COMEDSPA prospective, controlled, one year randomized trial

2025Advances in therapyPubMed

Real-World Effectiveness and Safety of Infliximab Biosimilar CT-P13 for Rheumatic Diseases: A National Observational Cohort Study (ReFLECT)

2025Rheumatology (Oxford, England)PubMed

Do SMS/e-mail reminders increase influenza vaccination of rheumatoid arthritis patients under anti-TNF: a nested randomized controlled trial in the ART e-cohort

2025RMD openPubMed

METHOFRACT, a methotrexate osteopathy multicentre cohort study

2021The European respiratory journalPubMed

Methotrexate and rheumatoid arthritis associated interstitial lung disease

2021European journal of cancer (Oxford, England : 1990)PubMed

Baseline co-medications may alter the anti-tumoural effect of checkpoint inhibitors as well as the risk of immune-related adverse events

2021Annals of the rheumatic diseasesPubMed

EULAR points to consider for the diagnosis and management of rheumatic immune-related adverse events due to cancer immunotherapy with checkpoint inhibitors

2023Annals of the rheumatic diseasesPubMed

Correspondence on 'Factors associated with progression to inflammatory arthritis in first-degree relatives of individuals with RA following autoantibody positive screening in a non-clinical setting'

2021Science translational medicinePubMed

Selectins impair regulatory T cell function and contribute to systemic lupus erythematosus pathogenesis

2021The Journal of rheumatologyPubMed

Real-world Risk of Relapse of Giant Cell Arteritis Treated With Tocilizumab: A Retrospective Analysis of 43 Patients

2023Microbiology spectrumPubMed

Effects of Lumacaftor-Ivacaftor on Airway Microbiota-Mycobiota and Inflammation in Patients with Cystic Fibrosis Appear To Be Linked to Pseudomonas aeruginosa Chronic Colonization

2025Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USAPubMed

Oncogenic rickets diagnosed at age 8 and the risk of persistent rickets: a rare case of pediatric-onset tumor-induced osteomalacia

2025Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USAPubMed

Oncogenic rickets diagnosed at age 8 and the risk of persistent rickets: a rare case of pediatric-onset tumor-induced osteomalacia

2020Autoimmunity reviewsPubMed

Worldwide trends in all-cause mortality of auto-immune systemic diseases between 2001 and 2014

2023Rheumatology (Oxford, England)PubMed

Stricter treat-to-target in RA does not result in less radiographic progression: a longitudinal analysis in RA BIODAM

2025 · Article

METHOFRACT, a methotrexate osteopathy multicentre cohort study

2024 · Article

Do SMS/e-mail reminders increase influenza vaccination of rheumatoid arthritis patients under anti-TNF: a nested randomized controlled trial in the ART e-cohort

2024 · Article

Towards the Lowest Efficacious Dose: Results From a Multicenter Noninferiority Randomized Open‐Label Controlled Trial Assessing Tocilizumab or Abatacept Injection Spacing in Rheumatoid Arthritis in Remission

2024 · Article

Towards the lowest efficacious dose (ToLEDo): results of a multicenter non‐inferiority randomized open‐label controlled trial assessing Tocilizumab or Abatacept injection spacing in rheumatoid arthritis in remission

2023 · Article

Can efficacy and safety data from clinical trials of rituximab in RA be extrapolated? Insights from 1984 patients from the AIR-PR Registry

2023 · Article

Effects of Lumacaftor-Ivacaftor on Airway Microbiota-Mycobiota and Inflammation in Patients with Cystic Fibrosis Appear To Be Linked to Pseudomonas aeruginosa Chronic Colonization

2023 · Article

Clinical and immunological features of patients with cancer-associated systemic sclerosis: An observational study

2022 · Article

JAK inhibitors and risk of major cardiovascular events or venous thromboembolism: a self-controlled case series study